Scarica l'app Stockscreener
0.2134
4.09%
-0.0091
Dopo l'orario di chiusura:
.21
-0.0034
-1.59%
Precedente Chiudi:
$0.2225
Aprire:
$0.22
Volume 24 ore:
1.36M
Relative Volume:
0.42
Capitalizzazione di mercato:
$49.28M
Reddito:
-
Utile/perdita netta:
$-67.01M
Rapporto P/E:
-0.6276
EPS:
-0.34
Flusso di cassa netto:
$-8.50M
1 W Prestazione:
-15.82%
1M Prestazione:
-16.48%
6M Prestazione:
-74.80%
1 anno Prestazione:
-58.88%
Intervallo 1D:
$0.2002
$0.223
Intervallo di 1 settimana:
$0.2002
$0.2638
Portata 52W:
$0.2002
$2.10
Lunai Bioworks Inc Stock (RENB) Company Profile
Nome
Lunai Bioworks Inc
Settore
Industria
Telefono
45 39179840
Indirizzo
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Confronta RENB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RENB
Lunai Bioworks Inc
|
0.2134 | 52.54M | 0 | -67.01M | -8.50M | -0.34 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Lunai Bioworks Inc Borsa (RENB) Ultime notizie
Order flow analysis tools used on Renovaro Inc.July 2025 Selloffs & Verified Entry Point Detection - Newser
Published on: 2025-08-28 20:54:17 - Newser
Applying Elliott Wave Theory to Renovaro Inc.2025 Price Action Summary & Verified Momentum Stock Ideas - Newser
Chart overlay techniques for tracking Renovaro Inc.Weekly Trade Analysis & Risk Controlled Swing Alerts - Newser
Will Renovaro Inc. stock go up soonWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
What earnings revisions data tells us about Renovaro Inc.Trade Performance Summary & Growth Focused Entry Point Reports - Newser
Quantitative breakdown of Renovaro Inc. recent moveIPO Watch & Expert Curated Trade Ideas - Newser
Evaluating Renovaro Inc. with trendline analysisJuly 2025 Fed Impact & Stock Portfolio Risk Management - Newser
Applying Wyckoff theory to Renovaro Inc. stockJuly 2025 Drop Watch & Capital Protection Trading Alerts - Newser
Can volume confirm reversal in Renovaro Inc.2025 Market Sentiment & Community Driven Trade Alerts - Newser
When is the best time to exit Renovaro Inc.Weekly Stock Analysis & Low Risk Growth Stock Ideas - Newser
can renovaro inc. stock recover from recent declineJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - Newser
Published on: 2025-08-27 22:01:42 - Newser
Is Renovaro Inc. a candidate for recovery playWeekly Stock Summary & Weekly High Potential Alerts - Newser
What the charts say about Renovaro Inc. todayBull Run & Free Long-Term Investment Growth Plans - Newser
Published on: 2025-08-27 19:26:06 - Newser
Can technical indicators confirm Renovaro Inc.’s reversalQuarterly Market Summary & AI Forecast for Swing Trade Picks - Newser
Is Renovaro Inc. forming bullish engulfing patterns2025 Market Sentiment & Stock Market Timing Techniques - sundaytimes.kr
Renovaro Inc. stock retracement – recovery analysis2025 Technical Overview & Risk Controlled Swing Trade Alerts - Newser
Renovaro Rebrands to Lunai Bioworks, Emphasizing AI in Biodefense - AInvest
Renovaro (RENB) Rebrands to Lunai Bioworks, Emphasizing AI in Biodefense - GuruFocus
Published on: 2025-08-27 10:45:40 - Newser
Advanced analytics toolkit walkthrough for Renovaro Inc.2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Lunai Bioworks: Building a Defensible Moat with AI-Driven Biotechnology in High-Growth Markets - AInvest
Renovaro BioSciences to change corporate name to ‘Lunai Bioworks’ - TipRanks
Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics | RENB Stock News - GuruFocus
Renovaro Inc. Changes Name to Lunai Bioworks, Focusing on AI-Driven Biodefense and Drug Discovery. - AInvest
Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics | FinancialContent - FinancialContent
Exit strategy if you’re trapped in Renovaro Inc.Weekly Earnings Recap & Real-Time Chart Breakout Alerts - Newser
Renovaro Inc. changes corporate name to Lunai Bioworks Inc., maintains Nasdaq symbol - Investing.com
Published on: 2025-08-26 14:39:00 - Newser
How to recover losses in Renovaro Inc. stockMarket Risk Report & Reliable Trade Execution Plans - Newser
Does Renovaro Inc. qualify in momentum factor screeningMarket Volume Report & High Accuracy Trade Signal Alerts - Newser
Applying big data sentiment scoring on Renovaro Inc.Trade Volume Report & Scalable Portfolio Growth Methods - Newser
Published on: 2025-08-26 10:59:38 - Newser
Leading vs lagging indicators on Renovaro Inc. performanceMarket Trend Report & Community Verified Watchlist Alerts - Newser
Key resistance and support levels for Renovaro Inc.Market Sentiment Review & Long-Term Growth Plans - Newser
Regression analysis insights on Renovaro Inc. performanceJuly 2025 Update & High Accuracy Swing Entry Alerts - Newser
Screener Results Flag Renovaro Inc. as OversoldJuly 2025 Short Interest & Daily Entry Point Alerts - beatles.ru
Key metrics from Renovaro Inc.’s quarterly dataEntry Point & Weekly High Potential Alerts - Newser
How Renovaro Inc. stock performs during market volatility2025 Technical Patterns & Smart Investment Allocation Insights - Newser
Does Renovaro Inc. have pricing powerInsider Selling & Long-Term Growth Plans - theviewers.co.kr
Published on: 2025-08-24 06:12:51 - Newser
Lunai Bioworks Inc Azioni (RENB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):